Antibodies against Manalpha1,2-Manalpha1,2-Man oligosaccharide structures recognize envelope glycoproteins from HIV-1 and SIV strains
about
Antibody 2G12 Recognizes Di-Mannose Equivalently in Domain- and Nondomain-Exchanged Forms but Only Binds the HIV-1 Glycan Shield if Domain ExchangedAnti-Retroviral Lectins Have Modest Effects on Adherence of Trichomonas vaginalis to Epithelial Cells In Vitro and on Recovery of Tritrichomonas foetus in a Mouse Vaginal ModelEnvelope glycans of immunodeficiency virions are almost entirely oligomannose antigens.The glycan shield of HIV is predominantly oligomannose independently of production system or viral clade.Very few substitutions in a germ line antibody are required to initiate significant domain exchange.Structure-based vaccine design in HIV: blind men and the elephant?Preparation and analysis of glycan microarraysHigh-mannose glycan-dependent epitopes are frequently targeted in broad neutralizing antibody responses during human immunodeficiency virus type 1 infection.Photogenerated lectin sensors produced by thiol-ene/yne photo-click chemistry in aqueous solution2G12-expressing B cell lines may aid in HIV carbohydrate vaccine design strategies.Potential of carbohydrate-binding agents as therapeutics against enveloped viruses.Discovery of novel anti-HIV active G-quadruplex-forming oligonucleotides.Actinohivin, a broadly neutralizing prokaryotic lectin, inhibits HIV-1 infection by specifically targeting high-mannose-type glycans on the gp120 envelope.Synthetically defined glycoprotein vaccines: current status and future directions.The antiretroviral lectin cyanovirin-N targets well-known and novel targets on the surface of Entamoeba histolytica trophozoites.Conference report: "Functional Glycomics in HIV Type 1 Vaccine Design" workshop report, Bethesda, Maryland, April 30-May 1, 2012.Antibodies expose multiple weaknesses in the glycan shield of HIV.
P2860
Q27664038-5CEE651B-68E9-4797-8728-57FE523A52AEQ28547132-BB23D136-9E4A-4FEF-A3F5-F9A270F49FFBQ33636347-60AC9BB9-05BE-4441-8B5F-B827C9A9CA6DQ33999756-1893B08B-9A76-4F20-BA31-FA94F0C8691AQ34178341-2A039B5A-278C-4852-8562-3A1E50884374Q34987048-BD2F1248-2DB1-4B58-BC54-A6DE540D0684Q34990847-AAA3CB90-9ACD-49F6-99A0-2FA9EE1A27A5Q35826509-7DFF7A1D-A162-48A9-81B9-6E8283A0B409Q36119844-06BE4A87-A521-4887-9F1A-C838EF1708F2Q36607316-0DC7EB56-748B-409F-8CC1-22DD82670B51Q37767654-83914EA0-11CF-4AD9-A4BF-D9F4468D1072Q38337453-3AD5F271-8F73-4CED-8364-41094366CFD5Q38343814-6CDAC1C9-EF87-43AE-81CC-B47242FBB1BAQ39375701-6BAB055C-0B31-41DE-93DB-7E906BD813ABQ41959304-74BCB4F0-6A4C-411D-B1CA-AD1075A07E9BQ42933039-9CE6794C-77A1-4FF3-9A5C-3584634E102FQ47681955-E1866D7F-5CFF-4299-BB3B-35D714EC1C2C
P2860
Antibodies against Manalpha1,2-Manalpha1,2-Man oligosaccharide structures recognize envelope glycoproteins from HIV-1 and SIV strains
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Antibodies against Manalpha1,2 ...... ins from HIV-1 and SIV strains
@ast
Antibodies against Manalpha1,2 ...... ins from HIV-1 and SIV strains
@en
type
label
Antibodies against Manalpha1,2 ...... ins from HIV-1 and SIV strains
@ast
Antibodies against Manalpha1,2 ...... ins from HIV-1 and SIV strains
@en
prefLabel
Antibodies against Manalpha1,2 ...... ins from HIV-1 and SIV strains
@ast
Antibodies against Manalpha1,2 ...... ins from HIV-1 and SIV strains
@en
P2093
P2860
P356
P1433
P1476
Antibodies against Manalpha1,2 ...... ins from HIV-1 and SIV strains
@en
P2093
Caroline Agrawal-Gamse
David F Smith
Robert J Luallen
Robert W Doms
P2860
P304
P356
10.1093/GLYCOB/CWP184
P577
2009-11-17T00:00:00Z